Innoviva (INVA) FCF Margin (QoQ) (2011 - 2025)
Innoviva (INVA) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
| Date | Value |
|---|
| Sep 30, 2025 |
8,712.00 |
| Jun 30, 2025 |
-1,090.00 |
| Sep 30, 2024 |
10,056.00 |
| Jun 30, 2024 |
-379,133.00 |
| Sep 30, 2023 |
-373,622.00 |
| Jun 30, 2023 |
67,364.00 |
| Sep 30, 2022 |
1.06 Mn |
| Jun 30, 2022 |
-373,973.00 |
| Sep 30, 2021 |
-697,312.00 |
| Jun 30, 2021 |
-64,561.00 |
| Mar 31, 2021 |
-903,067.00 |
| Dec 31, 2020 |
1.68 Mn |
| Sep 30, 2020 |
-1,701.00 |
| Jun 30, 2020 |
770.00 |
| Mar 31, 2020 |
533.00 |
| Dec 31, 2019 |
75.00 |
| Sep 30, 2019 |
-83.00 |
| Jun 30, 2019 |
-5,078.00 |
| Mar 31, 2019 |
6,155.00 |
| Dec 31, 2018 |
-2,010.00 |
